Optimizing Management of Bipolar Disorder in Children CME/CE

Author Information and Disclosures

Release Date: March 28, 2008; Valid for credit through March 28, 2009

Credits Available
Physicians - maximum of 1.5 AMA PRA Category 1 Credit(s)™ for physicians;
Nurses - 1.5 nursing contact hours (0.5 contact hours are in the area of pharmacology)

To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

Contents of This CME/CE Activity

Legal Disclaimer

The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

Copyright © 2008 Medscape.
BMS
Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Describe the clinical presentation of bipolar in children and adolescents
  2. Recognize the risk factors and prodromal symptoms that could predict the development of bipolar disorder in pediatric populations
  3. Identify the differences in the clinical presentation of symptoms in children, adolescents and adults and the importance of early and accurate diagnosis
  4. Evaluate effective pharmacologic and non-pharmacologic treatment options for children and adolescents, and identify key issues in successful management.
Authors and Disclosures

Robert A. Kowatch, MD, PhD
Disclosure: Robert A. Kowatch, MD, PhD, has disclosed that he has received research support from Bristol-Myers Squibb, Stanley Research Foundation, NIMH, and NICHD. Dr. Kowatch has also disclosed that he has served as a consultant and is on the Advisory Board for Creative Educational Concepts, CABF, Abbott, sanofi-aventis, and GSK. Dr. Kowatch has also disclosed that he has served as an editor for Current Psychiatry and on the speaker's bureau for Astra-Zeneca and Abbott.


Priscilla Scherer
Disclosure: Priscilla Scherer has disclosed no relevant financial relationships.


Anne E. Zitron, PhD
Disclosure: Anne E. Zitron, PhD, has disclosed no relevant financial relationships.
 
Medscape
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

 
This Activity is sponsored by Medscape Continuing Education Provider Unit.

Medscape is an approved provider of continuing nursing education by the New York State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.

Awarded 1.5 contact hour(s) of continuing nursing education for RNs and APNs; 0.5 contact hours are in the area of pharmacology.

Provider Number: 6FDKKC-PRV-05

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.